.
.
.
.
Coronavirus

India tells overseas COVID-19 vaccine buyers it has to prioritize local needs

Published: Updated:

India, the world’s biggest vaccine maker, said on Friday it would make domestic COVID-19 inoculations a priority as infections surge and had told international buyers of its decision.

Reports that India will delay deliveries of AstraZeneca’s COVID-19 vaccine to a global program to inoculate poorer countries triggered alarm on Thursday, with the head of Africa’s disease control agency describing the continent as “helpless.”

For more coronavirus news, visit our dedicated page.

India has exported 60.5 million doses, more than the number of inoculations conducted at home, and says there is no outright ban on exports, and vaccine supply will be staggered.

For all the latest headlines follow our Google News channel online or via the app.

“In the coming weeks and months ... obviously there will be a demand spike and obviously people are preparing for it,” Subrahmanyam Jaishankar told the Times Network’s India Economic Enclave.

“In many cases, we have told our international partners that ... COVID rates are going up in India, we are expanding our own vaccination ambit, so we are sure you will understand that at this time we have to purpose it much more focused at where we are.”

The Gavi alliance said in a statement that the COVAX vaccine-sharing facility had notified all affected economies of potential delays of exports by the Serum Institute of India (SII).

India is diverting more supplies from SII to inoculations at home. Its other vaccine maker, Bharat Biotech, is struggling to boost output.

“SII has pledged that, alongside supplying India, it will prioritize the COVAX multilateral solution for equitable distribution,” Gavi said.

COVAX is a global vaccine allocation plan co-led by the World Health Organization and partners including the Gavi alliance.

India on Friday reported 59,118 new infections, taking its tally to 11.85 million, the world’s third largest after the United States and Brazil. The death toll rose by 257 to stand at 160,949.

Everyone above 45 in India is eligible for vaccination from April 1 and the government is considering including more people after new infections nearly quadrupled this month.

“The government is already planning to widen the umbrella of COVID-19 vaccine beneficiaries in the near future to cover other sections of our population,” Health Minister Harsh Vardhan told a virtual summit organized by the Economic Times newspaper.

India has injected 55 million vaccine doses, the third highest figure after the United States and Brazil, although much lower as a proportion of its population of 1.35 billion, the website Our World in Data showed.



The western state of Maharashtra, hardest hit by a resurgence in cases, has warned of vaccine shortages and imposed lockdowns in some towns.

Authorities have also warned of a strict lockdown in Pune district, which on Thursday reported a record 6,427 new cases, the highest in the country.

“If the current surge in coronavirus cases remains there for the next few days, there will be no option but to impose a strict lockdown in Pune from April 2,” Maharashtra’s deputy chief minister, Ajit Pawar, told a news conference.

As beds run short in hospitals in the state, authorities said a fire in one hospital near Mumbai killed 10 patients, most of them COVID-19 sufferers.

Read more:

Alarm in Africa after India delays vaccines to COVAX program for poor countries

India reports second surge with over 47,000 daily infections, most deaths this year

India detects novel coronavirus variant